BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37290904)

  • 1. Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia.
    Xue W; Cang W; Zhao J; Feng F; Wan X; Ren T; Qiu L; Yang J; Xiang Y
    Int J Gynecol Cancer; 2023 Aug; 33(8):1222-1226. PubMed ID: 37290904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
    Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial.
    Jiang F; Mao MY; Xiang Y; Lu X; Guan CL; Jiao LZ; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
    BMC Cancer; 2023 Aug; 23(1):784. PubMed ID: 37612621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the multiples of the median of serum anti-müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case-control study.
    Lai THT; Lau LSK; Ngu SF; Chu MYM; Chan KKL; Ng EHY; Ngan HYS; Li RHW; Tse KY
    Cancer Med; 2024 Apr; 13(7):e7134. PubMed ID: 38545760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Single Radioactive Iodine Treatment Has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study.
    Yaish I; Azem F; Gutfeld O; Silman Z; Serebro M; Sharon O; Shefer G; Limor R; Stern N; Tordjman KM
    Thyroid; 2018 Apr; 28(4):522-527. PubMed ID: 29466932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of women diagnosed and treated for low-risk gestational trophoblastic neoplasia at the Queensland Trophoblast Centre (QTC).
    Verhoef L; Baartz D; Morrison S; Sanday K; Garrett AJ
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):458-463. PubMed ID: 28345753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian Hormone in Patients Treated with Chemotherapy for Gestational Trophoblastic Neoplasia Does Not Predict Short-Term Fertility.
    Ghorani E; Ramaswami R; Smith RJ; Savage PM; Seckl MJ
    J Reprod Med; 2016; 61(5-6):205-9. PubMed ID: 27424359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
    J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
    Lawrie TA; Alazzam M; Tidy J; Hancock BW; Osborne R
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD007102. PubMed ID: 27281496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian hormone levels in patients with gestational trophoblastic neoplasia treated with different chemotherapy regimens: a prospective cohort study.
    Bi X; Zhang J; Cao D; Sun H; Feng F; Wan X; Xiang Y; Qiu L; Cheng X; Yang J; Shen K
    Oncotarget; 2017 Dec; 8(69):113920-113927. PubMed ID: 29371957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pulsed actinomycin D versus 5-day methotrexate for the treatment of low-risk gestational trophoblastic disease.
    Mousavi A; Cheraghi F; Yarandi F; Gilani MM; Shojaei H
    Int J Gynaecol Obstet; 2012 Jan; 116(1):39-42. PubMed ID: 21996593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review.
    Anderson RA; Cameron D; Clatot F; Demeestere I; Lambertini M; Nelson SM; Peccatori F
    Hum Reprod Update; 2022 May; 28(3):417-434. PubMed ID: 35199161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic neoplasia: a meta-analysis evaluating reproductive and obstetrical outcomes after administration of chemotherapy.
    Tranoulis A; Georgiou D; Sayasneh A; Tidy J
    Int J Gynecol Cancer; 2019 Jul; 29(6):1021-1031. PubMed ID: 31253638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pulsed actinomycin D and 5-day actinomycin D as first-line chemotherapy for low-risk gestational trophoblastic neoplasia.
    Mu X; Song L; Li Q; Yin R; Zhao X; Wang D
    Int J Gynaecol Obstet; 2018 Nov; 143(2):225-231. PubMed ID: 30051913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China.
    Wang S; Pei L; Hu T; Jia M; Wang S
    Hum Reprod; 2021 Mar; 36(4):976-986. PubMed ID: 33411897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia.
    Yarandi F; Eftekhar Z; Shojaei H; Kanani S; Sharifi A; Hanjani P
    Int J Gynaecol Obstet; 2008 Oct; 103(1):33-7. PubMed ID: 18632105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
    Li Y; Kong Y; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
    Oncologist; 2021 Dec; 26(12):e2209-e2216. PubMed ID: 34396643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia].
    Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279
    [No Abstract]   [Full Text] [Related]  

  • 19. Ovarian reserve in premenopausal women with breast cancer.
    Zong X; Yu Y; Chen W; Zong W; Yang H; Chen X
    Breast; 2022 Aug; 64():143-150. PubMed ID: 35691250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
    Sato S; Yamamoto E; Niimi K; Ino K; Nishino K; Suzuki S; Kotani T; Kajiyama H; Kikkawa F
    Int J Clin Oncol; 2020 Jan; 25(1):203-209. PubMed ID: 31520175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.